Related Experiment Video
Updated: Dec 30, 2025

Generation of a Three-dimensional Full Thickness Skin Equivalent and Automated Wounding
Published on: February 26, 2015
Human Skin Keratinocytes on Sustained TGF-β Stimulation Reveal Partial EMT Features and Weaken Growth Arrest
Sergio Liarte1, Ángel Bernabé-García1, Francisco J Nicolás1
1Laboratorio de Regeneración, Oncología Molecular y TGF-β, IMIB-Arrixaca, El Palmar, 30120 Murcia, Spain.
Abstract:
Defects in wound closure can be related to the failure of keratinocytes to re-epithelize. Potential mechanisms driving this impairment comprise unbalanced cytokine signaling, including Transforming Growth Factor-β (TFG-β). Although the etiologies of chronic wound development are known, the relevant molecular events are poorly understood. This lack of insight is a consequence of ethical issues, which limit the available evidence to humans. In this work, we have used an in vitro model validated for the study of epidermal physiology and function, the HaCaT cells to provide a description of the impact of sustained exposure to TGF-β. Long term TGF-β1 treatment led to evident changes, HaCaT cells became spindle-shaped and increased in size. This phenotype change involved conformational re-arrangements for actin filaments and E-Cadherin cell-adhesion structures. Surprisingly, the signs of consolidated epithelial-to-mesenchymal transition were absent. At the molecular level, modified gene expression and altered protein contents were found. Non-canonical TGF-β pathway elements did not show relevant changes. However, R-Smads experienced alterations best characterized by decreased Smad3 levels. Functionally, HaCaT cells exposed to TGF-β1 for long periods showed cell-cycle arrest. Yet, the strength of this restraint weakens the longer the treatment, as revealed when challenged by pro-mitogenic factors. The proposed setting might offer a useful framework for future research on the mechanisms driving wound chronification.
Insights
Sustained Transforming Growth Factor-β (TGF-β) exposure alters keratinocyte behavior, impacting wound healing. This study reveals TGF-β1 causes cell shape changes and cell-cycle arrest in HaCaT cells, offering insights into chronic wound mechanisms.
Area of Science:
- Cell Biology
- Wound Healing Research
- Molecular Mechanisms
Background:
- Defects in keratinocyte re-epithelialization impair wound closure.
- Unbalanced cytokine signaling, including Transforming Growth Factor-β (TGF-β), is implicated in wound healing impairment.
- Molecular events underlying chronic wound development are poorly understood due to limited human studies.
Purpose of the Study:
- To investigate the impact of sustained Transforming Growth Factor-β1 (TGF-β1) exposure on HaCaT cells, an in vitro model for epidermal studies.
- To elucidate molecular and functional changes in keratinocytes under long-term TGF-β1 stimulation.
- To explore potential mechanisms contributing to wound chronification.
Main Methods:
- Utilized the HaCaT cell line as an in vitro model for epidermal physiology.
- Applied long-term treatment with TGF-β1 to HaCaT cells.
- Analyzed cellular morphology, actin filament and E-Cadherin organization, gene expression, protein content, R-Smad levels, and cell-cycle progression.
Main Results:
- Long-term TGF-β1 treatment induced significant morphological changes in HaCaT cells, including a spindle-shaped phenotype and increased size.
- Observed alterations in actin filaments and E-Cadherin, but without consolidated epithelial-to-mesenchymal transition.
- Detected modified gene expression, altered protein content, decreased Smad3 levels, and initial cell-cycle arrest that weakened over time.
Conclusions:
- Sustained TGF-β1 exposure significantly impacts keratinocyte phenotype and cell-cycle regulation.
- The study provides a framework for understanding molecular events in chronic wound development.
- Further research using this model can elucidate mechanisms driving wound chronification.
More Related Videos
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
TGF - β Signaling Pathway
Clinical Applications of Epidermal Stem Cells
Multipotency and Niche of Bulge Stem Cell

